Ziextenzo Cost Without Insurance — US Pharmacy Price Guide

Our most recent US pharmacy data shows a low of roughly $3,841.17 for Ziextenzo with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Generic and brand-name pricing for Ziextenzo is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

The cost of Ziextenzo with insurance depends on your specific health plan's coverage and formulary. Your out-of-pocket expense will typically be a copay or coinsurance amount, which can vary widely. Some insurance plans may not cover Ziextenzo, or they may require prior authorization. To determine your exact cost, contact your insurance provider directly. If your copay is high or if the medication is not covered, you might consider using a prescription savings card, as its price could be lower than your insurance copay. Patients with government-sponsored plans like Medicare or Medicaid should also verify their coverage details.

Ziextenzo is a biosimilar to Neulasta, with the active ingredient pegfilgrastim-bmez. It is manufactured by Sandoz. As of now, there is no FDA-approved generic (bioequivalent) version of pegfilgrastim-bmez available on the market. Biosimilars are highly similar to a reference biologic product and have no clinically meaningful differences in terms of safety and effectiveness.